Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/23/2011 | WO2011051489A3 Albumin variants |
06/23/2011 | WO2011048566A9 A means for inducing apomixis in cultivated plants having sexual reproduction and use thereof for the production of completely or partially apomictic plants |
06/23/2011 | WO2011045573A3 Staphylococcal antigens |
06/23/2011 | WO2011044698A8 Multi epitope vaccine for poultry |
06/23/2011 | WO2011044186A9 Human single-chain t cell receptors |
06/23/2011 | WO2011038900A3 Peptide analogues of glucagon for diabetes therapy |
06/23/2011 | WO2011036563A9 Structure of the n-rna complex of the non-segmented negative-strand rna viruses of the paramyxoviridae family |
06/23/2011 | WO2011036444A4 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
06/23/2011 | WO2011022394A3 Materials and methods for the development of an antigen-specific immune non-responsiveness state |
06/23/2011 | WO2011020033A3 Engineered proteins including mutant fibronectin domains |
06/23/2011 | WO2011020024A3 Methods of modulating immune function |
06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
06/23/2011 | WO2010141430A3 A cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof |
06/23/2011 | WO2010136583A3 INDUCED DERIVATION OF SPECIFIC ENDODERM FROM hPS CELL-DERIVED DEFINITIVE ENDODERM |
06/23/2011 | WO2010131917A3 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof |
06/23/2011 | WO2010129023A3 Supercharged proteins for cell penetration |
06/23/2011 | WO2010075960A8 Method for producing riboflavin |
06/23/2011 | WO2010069950A9 Bidirectional promoter from z. mais |
06/23/2011 | WO2009153458A9 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
06/23/2011 | WO2003056914A9 Methods to engineer mammalian-type carbohydrate structures |
06/23/2011 | US20110154541 Bio-engineered photosystems |
06/23/2011 | US20110154539 Control of fruit dehiscence in plants by indehiscent1 genes |
06/23/2011 | US20110154536 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
06/23/2011 | US20110154535 Novel Bacillus thuringiensis Gene with Coleopteran Activity |
06/23/2011 | US20110154532 Compositions and methods related to silicon transport |
06/23/2011 | US20110154530 Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof |
06/23/2011 | US20110154527 Soybean Gene for Resistance to Aphis Glycines |
06/23/2011 | US20110154522 BH3 Peptides And Method Of Use Thereof |
06/23/2011 | US20110154515 Genetically encoded calcium sensors comprising the c-terminal lobe of troponin c and a fluorescence tag |
06/23/2011 | US20110154514 Polynucleotide used for releasing recombinant protein to the outside of eukaryotic cell |
06/23/2011 | US20110152507 Processes for refolding of insulin |
06/23/2011 | US20110152506 Method for Purifying Erythropoietin |
06/23/2011 | US20110152502 Fluorescent protein |
06/23/2011 | US20110152501 Activatable Imaging Probes |
06/23/2011 | US20110152500 Bipodal-Peptide Binder |
06/23/2011 | US20110152193 Inhibitors of human plasmin derived from the kunitz domains |
06/23/2011 | US20110152187 Insulin-like growth factor fusion proteins |
06/23/2011 | US20110152183 Derivatised hybrid peptides of amylin and salmon calcitonin |
06/23/2011 | US20110152182 Oxyntomodulin peptide analogue |
06/23/2011 | US20110152181 Oxyntomodulin peptide analogue |
06/23/2011 | US20110152171 Histamine binding protein |
06/23/2011 | US20110152122 Compositions and Methods for the Identification and Use of Epigenetic Markers Useful in the Study of Normal and Abnormal Mammalian Gametogenesis |
06/23/2011 | US20110152107 Drug Screening Via Nanpore Silicon Filters |
06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
06/23/2011 | US20110151538 Affinity purification by cohesin-dockerin interaction |
06/23/2011 | US20110151483 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1 |
06/23/2011 | US20110151480 Methods of purifying zsig33 |
06/23/2011 | US20110151478 Transcriptional biomarkers and methods for detecting and isolating cancer cells in body fluids and tissue specimens |
06/23/2011 | US20110151473 Polynucleotides and Polypeptides Encoding Receptors |
06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
06/23/2011 | US20110151470 Biomarkers for assessing response to c-met treatment |
06/23/2011 | US20110151436 Compositions and methods for the detection of hiv-1/hiv-2 infection |
06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
06/23/2011 | US20110150930 Recombinant viral-based malaria vaccines |
06/23/2011 | US20110150921 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
06/23/2011 | US20110150920 Allergy Vaccines Containing Hybrid Polypeptides |
06/23/2011 | US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer |
06/23/2011 | US20110150917 Small Cationic Antimicrobial Peptides |
06/23/2011 | US20110150916 Compositions and methods for treatment of group a streptococci |
06/23/2011 | US20110150915 Polyvalent vaccine |
06/23/2011 | US20110150914 Compositions and methods for dengue virus (dv) treatment and vaccination |
06/23/2011 | US20110150913 Torque teno virus (ttv) isolates and compositions |
06/23/2011 | US20110150911 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
06/23/2011 | US20110150910 Methods of inducing an immune response |
06/23/2011 | US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho |
06/23/2011 | US20110150889 Haemophilus influenzae type iv pili |
06/23/2011 | US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis |
06/23/2011 | US20110150884 Crystalline composition of gm-csf/gm-csfr |
06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |
06/23/2011 | US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer |
06/23/2011 | US20110150877 Ephrin-b receptor protein involved in carcinoma |
06/23/2011 | US20110150875 Egf-a domain-mediated modulation of pcks9 for treating lipid disorders |
06/23/2011 | US20110150872 Soluble heterodimeric cytokine receptor |
06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
06/23/2011 | US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
06/23/2011 | US20110150841 Secretion System and Methods for its Use |
06/23/2011 | US20110150828 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
06/23/2011 | US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
06/23/2011 | US20110150768 Compositions and methods for delivering inhibitory oligonucleotides |
06/23/2011 | US20110150761 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
06/23/2011 | CA2784784A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
06/23/2011 | CA2784624A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
06/23/2011 | CA2784488A1 Injection needle and device |
06/23/2011 | CA2784093A1 Wise binding agents and epitopes |
06/23/2011 | CA2782815A1 Decellularized adipose tissue |
06/23/2011 | CA2782093A1 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
06/23/2011 | CA2778872A1 A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands |
06/23/2011 | CA2778871A1 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
06/22/2011 | EP2336775A2 High affinity TCR proteins and methods |
06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
06/22/2011 | EP2336366A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
06/22/2011 | EP2336365A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
06/22/2011 | EP2336364A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
06/22/2011 | EP2336357A1 S. pneumoniae antigens |
06/22/2011 | EP2336339A2 Production of viral vectors |
06/22/2011 | EP2336338A2 Transgenic non-human animals for pharmacological and toxicological studies |
06/22/2011 | EP2336337A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
06/22/2011 | EP2336336A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |